Table 3 SIRs of second primary cancer by type of first primary cancer and sex
Sex | Males | Females | ||
|---|---|---|---|---|
First primary cancer | Obs. | SIR (95% CI) | Obs. | SIR (95% CI) |
Head/Neck/Larynx | 281 | 1.88 (1.67–2.11) | 53 | 1.74 (1.30–2.28) |
Stomach | 111 | 0.94 (0.77–1.13) | 57 | 0.83 (0.63–1.07) |
Colon/Rectum | 381 | 0.91 (0.82–1.00) | 233 | 0.89 (0.78–1.01) |
Lung | 130 | 0.90 (0.75–1.06) | 56 | 1.58 (1.19–2.05) |
Melanoma | 133 | 0.93 (0.78–1.10) | 107 | 0.94 (0.77–1.14) |
Breast | 580 | 0.82 (0.75–0.89) | ||
Cervix | 102 | 1.40 (1.14–1.70) | ||
Endometrium | 177 | 1.08 (0.92–1.25) | ||
Ovary | 72 | 1.09 (0.85–1.37) | ||
Prostate | 1117 | 0.68 (0.64–0.72) | ||
Bladder | 300 | 1.20 (1.07–1.34) | 61 | 1.13 (0.86–1.45) |
Kidney | 162 | 1.22 (1.04–1.42) | 84 | 1.29 (1.03–1.59) |
Thyroid gland | 40 | 1.23 (0.88–1.67) | 79 | 1.40 (1.11–1.75) |
NHL high/low | 68 | 1.20 (0.93–1.53) | 43 | 1.23 (0.89–1.66) |
CLL/ALL | 34 | 0.93 (0.64–1.30) | 22 | 1.11 (0.69–1.67) |
All cancers combined | 3036 | 0.90 (0.86–0.93) | 1913 | 1.00 (0.96–1.05) |
All cancers except Prostate | 1919 | 1.10 (1.05–1.15) | ||